Biota (ASX:BTA) F2008 Annual Results - LANI (CS-8958) - HRV (BTA798) - RSV (BTA9881) Strong cash balances at $60.2 million Revenue and other income of $45 million, including Relenza Royalties of $20.5 million and collaboration income of $15.2 million Conclusion of...
Biota RSV licence assigned to AZ - territories expanded Melbourne, Australia and Alderly Park, United Kingdom - 26 August 2008 ...Biota Holdings Limited (ASX:BTA) and AstraZeneca (NYSE:AZN) today announced that the 2005 Collaboration and License Agreement with MedImmune has been assigned to...
Biota's balancing act Offshore merger and acquisition activity is playing out with mixed results for Australian biotech companies at the moment.While Schering-Ploughs buyout of Organon saw the dumping of its Acrux partnership, Biotas development deal with...
Biota records loss due to Relenza battle reported a full year loss after tax of $6.5 million compared to a $20.2 million profit last year.The result was affected by 48% decline in the royalties from Biota's bird flu vaccine Relenza and litigation costs of $21.8 million.CEO...
Biota records loss due to Relenza battle Biota Holdings Limited (BTA)reported a full year loss after tax of $6.5 million compared to a $20.2 million profit last year.The result was affected by 48% decline in the royalties from Biota's bird flu vaccine Relenza and...
Biota Announces F2008 Annual Results and Preliminary Final Report and Annual Report F2008 Annual Results HIGHLIGHTS Three products progressing in clinic - LANI (CS-8958) - HRV (BTA798) - RSV (BTA9881) Strong cash balances at $60.2 million Revenue and other income of $45 million, including Relenza Royalties of $20.5...
Biota clears the board in wake of settlement TWO directors of Melbourne drug developer Biota who oversaw the company's four-year battle with pharmaceuticals giant GlaxoSmithKline have announced they will leave the board following last month's legal settlement.The legal dispute...
Sequential Acquisition of Adjacent Vintage H1N1 Polymorphisms (08/21/08 22:35) Recently released H1N1 sequences from South Africa confirmed earlier reports indicating that Tamiflu (oseltamivir) resistance was running at 100% in the first 23 isolates sequenced.Recently, the South African data has been updated with...
GSK begins shipments of Fluarix and FluLaval to U.S. customers for 2008-2009 influenza season - (NewsRx.com) -- GlaxoSmithKline [NYSE: GSK] announced that it will begin shipment of FLULAVAL [Influenza Virus Vaccine] and FLUARIX [Influenza Virus Vaccine] to U.S.customers for the 2008-2009 influenza season.
The U.S.
Food and...
Biota defends Relenza settlement with GSK _ Biota defends Relenza settlement with GSK.
Tough Biotech Lesson Learned: Fighting Big Pharma is Costly Biota Settles with GSK By Nuala Moran BioWorld International Correspondent LONDON - Biota Holdings Ltd.has written to shareholders to explain why it dropped a four year-long legal action against GlaxoSmithKline plc over a claim that the...
More than 80 percent of Indonesia bird flu cases die WASHINGTON, UNITED STATES - Late diagnosis and treatment means that more than 80 percent of people infected with H5N1 avian influenza in Indonesia have died, researchers reported on Wednesday.An analysis of outbreaks in Indonesia, the...
More than 80% of Indonesia bird flu cases die WASHINGTON, US - LATE diagnosis and treatment means that more than 80 per cent of people infected with H5N1 avian influenza in Indonesia have died, researchers reported on Wednesday.An analysis of outbreaks in Indonesia, the country...
Flu drug scientist wins top award A Melbourne scientist who played a pivotal role in developing the world's first anti-influenza drug has won Victoria's top science award.Professor Peter Colman was awarded the $50,000 Victoria Prize on Wednesday night for his...
More than 80% of Indonesia bird flu cases die WASHINGTON - LATE diagnosis and treatment means that more than 80 per cent of people infected with H5N1 avian influenza in Indonesia have died, researchers reported on Wednesday.An analysis of outbreaks in Indonesia, the country hardest...
Colman wins Victoria Prize Professor Peter Colman, head of structural biology at the Walter and Eliza Hall Institute, has won the $50,000 Victoria Prize for science.The award, one of Australia's richest, was presented to Colman at a ceremony in Melbourne this...
Flu drug scientist wins top award A Melbourne scientist who played a pivotal role in developing the world's first anti-influenza drug has won Victoria's top science award.Professor Peter Colman was awarded the $50,000 Victoria Prize on Wednesday night for his...
Flu drug scientist wins top award A Melbourne scientist who played a pivotal role in developing the world's first anti-influenza drug has won Victoria's top science award.Professor Peter Colman was awarded the $50,000 Victoria Prize on Wednesday night for his...
Flu drug scientist wins top award A Melbourne scientist who played a pivotal role in developing the world's first anti-influenza drug has won Victoria's top science award.Professor Peter Colman was awarded the $50,000 Victoria Prize on Wednesday night for his...
Flu drug scientist wins top award (AAP) A Melbourne scientist who played a pivotal role in developing the world's first anti-influenza drug has won Victoria's top science award.Professor Peter Colman was awarded the $50,000 Victoria Prize on Wednesday night for his...
Flu drug scientist wins top award A Melbourne scientist who played a pivotal role in developing the world's first anti-influenza drug has won Victoria's top science award.Professor Peter Colman was awarded the $50,000 Victoria Prize on Wednesday night for his...
Flu drug scientist wins top award A Melbourne scientist who played a pivotal role in developing the world's first anti-influenza drug has won Victoria's top science award.Professor Peter Colman was awarded the $50,000 Victoria Prize on Wednesday night for his...
Flu fighter wins top science prize A MELBOURNE scientist whose groundbreaking research led to the development of the world's first anti-influenza drug has won Victoria's top science award Prof Peter Colman, who received the $50,000 Victoria Prize from Governor Prof David de...
Chinese researcher teams up US firm to treat bird flu An internationally renowned avian influenza expert from China has reported positive results from experiments conducted by his research team.This study demonstrated impressive efficacy of a novel statin/caffeine combination, StatC in the...
Chinese researcher finds exciting results from study on StatC An internationally renowned avian influenza expert hailed 'encouraging and exciting' results from experiments conducted by his research team.This study demonstrated impressive efficacy of a novel statin/caffeine combination, StatC in the...
